Skip to main content
Caplight Logo









Biorithm

Biorithm

Private
SingaporeHealthcare & Life Scienceshttps://www.bio-rithm.com/

Last Round

Series A

Dec 18, 2023

Total Funding Raised

$3.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Biorithm is a medical technology company that provides a remote maternal-fetal monitoring platform for personalized and connected maternity care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Healthcare Analytics, Telemedicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS

AI Layer

Application

Keywords

remote patient monitoringRPMmaternal healthfetal monitoringtelemedicinedigital healthwearable sensorsobstetricsclinical decision supporthealth IoTfemtechvirtual caremedical devicehealthcare analyticsvertical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biorithm Comparables

Compare Biorithm with similar companies based on industry and business-model similarity.

Biorithm comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bloomlife
91%
Marani Health
85%
Kali Healthcare
83%

Biorithm Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 18, 2023
AcceleratorJun 29, 2016

Biorithm Investors

Notable investors and investment history

Biorithm investors
InvestorRounds
SEEDS CapitalSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors grew 268% MoM, reaching 1.9K.

  • Apr 18, 2026

    Monthly visitors grew 2950% MoM, from 38 to 1.2K.

Biorithm Filings

Explore SEC and related filing metadata, where available.

Biorithm filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Biorithm's valuation, stock price, and market status.

Is Biorithm a public or private company?

Biorithm is a private company.

What is the current stock price of Biorithm?

Biorithm is a private company with no public stock price. No recent secondary market data is available.

How much is Biorithm worth (valuation)?

Valuation information for Biorithm is not publicly available.

Can I buy Biorithm stock?

Biorithm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Biorithm's last funding round?

Biorithm's most recent funding round was Series A on December 18, 2023.

Who are the main investors in Biorithm?

Key investors in Biorithm include SEEDS Capital.

Will Biorithm IPO soon?

No public IPO plans have been announced for Biorithm.

How can I track Biorithm secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biorithm's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Employee Range14
Year Founded2014
Last FundingDec 18, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?